Vicarious Surgical’s (RBOT) “Neutral” Rating Reaffirmed at BTIG Research

BTIG Research reissued their neutral rating on shares of Vicarious Surgical (NYSE:RBOT) in a research report sent to investors on Friday morning,Benzinga reports.

Several other analysts have also weighed in on the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Vicarious Surgical in a research note on Wednesday, October 8th. Wall Street Zen raised shares of Vicarious Surgical to a “sell” rating in a report on Saturday, September 13th. Two equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Reduce” and an average price target of $7.00.

Vicarious Surgical Trading Down 4.4%

NYSE RBOT opened at $2.59 on Friday. The firm’s 50 day simple moving average is $4.39 and its 200 day simple moving average is $6.49. The firm has a market capitalization of $16.96 million, a price-to-earnings ratio of -0.29 and a beta of 1.51. Vicarious Surgical has a 1 year low of $2.44 and a 1 year high of $18.97.

Vicarious Surgical (NYSE:RBOT) last announced its quarterly earnings data on Wednesday, November 12th. The company reported ($1.91) EPS for the quarter, beating the consensus estimate of ($2.37) by $0.46. On average, equities research analysts forecast that Vicarious Surgical will post -10.89 earnings per share for the current year.

Institutional Trading of Vicarious Surgical

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. DNB Asset Management AS lifted its position in shares of Vicarious Surgical by 12.1% in the 2nd quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock worth $219,000 after purchasing an additional 3,154 shares during the period. Dimensional Fund Advisors LP raised its stake in Vicarious Surgical by 22.1% during the third quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock worth $110,000 after buying an additional 3,615 shares during the last quarter. Finally, Connective Capital Management LLC acquired a new position in Vicarious Surgical in the third quarter valued at $169,000. Institutional investors and hedge funds own 47.27% of the company’s stock.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.